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This journal is ª The Royal Society ofUnravelling the behaviour of curcumin nanoemulsions
during in vitro digestion: eﬀect of the surface charge
Ana C. Pinheiro,a Mita Lad,b He´lder D. Silva,a Manuel A. Coimbra,c Michael Bolandb
and Anto´nio A. Vicente*a
Oil-in-water nanoemulsions containing curcumin were prepared through high-pressure homogenization
using corn oil and three diﬀerent emulsiﬁers: Tween 20 (non-ionic), Sodium Dodecyl Sulphate (SDS,
anionic) and DodecylTrimethylAmmonium Bromide (DTAB, cationic). A human gastric simulator was
used as the in vitro digestion model (in which the stomach, duodenum, jejunum and ileum steps were
performed) to evaluate the impact of surface charge on the digestion of the curcumin nanoemulsions.
This model allowed the simulation of continuous peristaltic movements and consequently enabled a
more mechanically realistic simulation of the dynamic digestion process than simple stirred vessel
models. The emulsiﬁer charge had a signiﬁcant eﬀect on the droplet size, particle electric charge and
microstructure of curcumin nanoemulsions during the simulated digestion, which consequently
inﬂuenced the free fatty acid release and curcumin bioavailability. The results showed the positively
charged DTAB-stabilized emulsions to be the least stable during the digestion process, exhibiting the
largest increase in droplet size and eventual phase separation. This also contributed to the low
bioavailability of curcumin. Conversely, emulsions stabilized with Tween 20 showed retention of
emulsion structure (high surface area) and greater free fatty acid production, which could explain the
increased curcumin bioavailability. The emulsiﬁer charge inﬂuenced the lipid digestion process and the
bioavailability of the bioactive compound incorporated, probably by altering the ability of bile salts and
digestive enzymes to adsorb onto the emulsion surfaces, thus altering the droplet size (and
consequently the surface area) due to droplet breakup or coalescence within the digestive tract. The
results of this work also highlighted the importance of subjecting the emulsions to a simulated gastric
environment, since changes in pH, ionic strength, gastric enzyme activity and shear will impact the
emulsion properties in the small-intestine. This manuscript has provided important insights into the
eﬀect of emulsiﬁer charge on the behaviour of nanoemulsions during in vitro digestion, which is
important to determine their functional performance, aiming at the optimization of nanoemulsion-
based delivery systems to protect and release bioactive lipophilic compounds.1 Introduction
Curcumin is a yellow pigment derived from the rhizomes of the
Curcuma longa (commonly known as turmeric). This natural
polyphenol is an important natural colorant used in food1 and
has gained considerable attention in recent years due to its wide
range of biological activities, such as anti-oxidant,2 anti-micro-
bial,3 anti-inammatory,4 wound healing5 and anti-tumoral
eﬀects.6 However, the applicability of curcumin as a health-
promoting agent is limited by its poor solubility in aqueousineering, Centre of Biological Engineering,
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Chemistry 2013solution and its low bioavailability. The reduced bioavailability
of curcumin is related to its poor absorption, rapid metabolism
and rapid systemic elimination.7 The bioavailability of poorly
water-soluble compounds such as curcumin can be greatly
enhanced by incorporating them into emulsion-based delivery
systems. An oil-in-water emulsion can be produced by homog-
enizing the oil phase containing the lipophilic bioactive
compound with an aqueous phase containing a water-soluble
emulsier.8 Emulsions can have a wide range of droplet sizes,
depending on the composition of the system and on themethod
of homogenization used. Emulsions formed on the nanometer
scale have better stability against droplet aggregation as the
attractive forces acting between the droplets decreases with
decreasing particle size. The bioavailability of encapsulated
lipophilic components within the gastrointestinal tract may, in
principle, be increased by using nanoemulsions due to the
small particle size and high surface-to-volume ratio.9Soft Matter, 2013, 9, 3147–3154 | 3147
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(pH 1 to 3) by the action of gastric lipase, which hydrolyses
about 10 to 30% of the ingested triacylglycerols, generating
mainly free fatty acids and diacylglycerols. This facilitates the
subsequent lipid hydrolysis in the duodenum by pancreatic
lipase by allowing fat emulsication and promoting enzyme
activity.10 The encapsulated lipophilic bioactive compound is
released upon digestion of the emulsion and is incorporated
into the bile salt/phospholipid micelles (mixed micelles) and
then transported through the mucous layer to the surfaces of
the enterocytes where it is absorbed.11 The formation of mixed
micelles facilitates the molecular absorption of lipophilic
compounds from the small intestine into the bloodstream.12
In recent years, diﬀerent in vitro digestion models have been
developed as a means for understanding the physicochemical
processes associated with the digestion process. The pH-stat
method is a simple in vitro lipolysis model commonly used to
characterize the lipid digestion under simulated small intes-
tinal conditions. This method allows the measurement of the
free fatty acids (FFA) released from triacylglycerols over time
and can be used to rapidly evaluate the impact of diﬀerent
formulations or conditions on lipid digestion.13 Some of the
complex dynamic gastrointestinal models include the dynamic
gastric model (DGM), which was designed to replicate the real-
time changes in pH, enzyme addition, shearing, mixing and
retention time of an adult human stomach,14 the TIM model,
which simulates the physiological conditions of the human
stomach and small intestine,15 and the Human Gastric Simu-
lator (HGS), a model that allows for the simulation of the
continuous peristaltic movements of stomach walls with similar
amplitude and frequency of contraction forces as reported
in vivo.16 This model also incorporates gastric secretion,
emptying systems and temperature control that enable a more
realistic simulation of the dynamic digestion process.
Most of the works that evaluate the behaviour of emulsions
during digestion use simple in vitro models that do not include
a gastric stage.17–19 The passage of nanoemulsions through the
highly acidic conditions in the stomach involves physical
destabilization of emulsions, once the composition, size and
interfacial characteristics of the lipid droplets are altered.20
Therefore, more realistic in vitro digestion models should
be used.
The emulsier type will impact the susceptibility of the lipid
droplets to coalescence and break up within the gastrointestinal
(GI) tract, thereby altering the total surface area of lipid exposed
to lipase absorption and activity.21 The characteristics of the
interfacial layer surrounding the lipid droplets will inuence
the ability of lipase to interact with the lipid phase, and
consequently, the rate of lipid digestion.
In the present work, the human gastric simulator model
was used to mimic the mechanical and chemical environments
of the human stomach, duodenum, jejunum and ileum. The
impact of the emulsier type on the structural changes of
curcumin nanoemulsions and on curcumin bioavailability
during in vitro digestion was evaluated. In particular, the
impact of emulsier charge was evaluated using Tween 20
(non-ionic), sodium dodecyl sulphate (SDS, anionic) and3148 | Soft Matter, 2013, 9, 3147–3154dodecyltrimethylammonium bromide (DTAB, cationic) as
emulsiers.2 Experimental
2.1 Materials
Corn oil was purchased from a local supermarket in Palmerston
North (New Zealand) and was used without further purication.
Curcumin, Tween 20 and sodium dodecyl sulphate (SDS) were
purchased from Sigma-Aldrich (St Louis, MO) and dodecyl-
trimethylammonium bromide (DTAB) was acquired from Acros
Organics. Pepsin from porcine gastric mucosa, amano lipase
A from Aspergillus niger, pancreatin from porcine pancreas
(8  USP), bile extract porcine and the salts used for preparing
the gastric electrolyte solution and the small intestinal elec-
trolyte solution, hydrochloric acid and sodium bicarbonate
were purchased from Sigma-Aldrich (St Louis, MO). Chloroform
was obtained from BDH chemicals (Poole, England).
Milli-Q water (water puried by treatment with Milli-Q
apparatus, Millipore Corp., Bedford, MA, USA) was used to
prepare all solutions.2.2 Emulsion preparation
The curcumin nanoemulsions were prepared by homogenizing
5 wt% corn oil containing 0.1 wt% of curcumin with 95 wt%
aqueous emulsier solution (0.5 wt% Tween 20, SDS or DTAB),
using a high-speed blender for 2 min followed by passage
through a microuidizer (Microuidics M-110P) at 20 000 psi
(137.9 MPa), for 5 cycles.2.3 In vitro digestion
In vitro digestion was performed by simulating the gastric,
duodenal, jejunal and ileal portions of the GI tract as described
by other authors15 with the following modications. A volume of
300 ml of curcumin nanoemulsions with the selected emulsier
was introduced into the human gastric simulator and the
experiment was run for a total of 5 h, simulating the average
physiological conditions of the gastrointestinal tract by the
continuous addition of gastric, duodenal, jejunal and ileal
secretions. The gastric secretion consisted of pepsin and lipase
in a gastric electrolyte solution (NaCl 4.8 g l1, KCl 2.2 g l1,
CaCl2 0.22 g l
1 and NaHCO3 1.5 g l
1), secreted at a ow rate of
0.5 ml min1. The pH was controlled to follow a predetermined
curve (from 4.8 at t ¼ 0 to 1.7 at t ¼ 120 min) by secreting
hydrochloric acid (1 M). The duodenal secretion consisted of a
mixture of 30 ml of 4% (w/v) porcine bile extract, 15 ml of 7%
(w/v) pancreatin solution and 9 ml of a small intestinal
electrolyte solution (SIES) (NaCl 5 g l1, KCl 0.6 g l1, CaCl2
0.25 g l1) at a ow rate of 0.9 ml min1. The jejunal secretion
uid consisted of SIES containing 10% (v/v) porcine bile extract
solution at a ow rate of 3.2 ml min1. The ileal secretion uid
consisted of SIES at a ow rate of 3.0 ml min1. The pH in the
diﬀerent parts of small intestine was controlled by the addition
of 1M sodium bicarbonate solutions to set-points of 6.5, 6.8 and
7.2 for simulated duodenum, jejunum and ileum, respectively.This journal is ª The Royal Society of Chemistry 2013
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The particle size of the emulsions was measured at diﬀerent
stages of digestion by both dynamic light scattering (Zetasizer
Nano ZS, Malvern Instruments, Worcestershire, UK) and static
light scattering (Mastersizer 2000 Hydro MU, Malvern Instru-
ments Ltd, Malvern, Worcestershire, UK).
The z-average mean diameter was calculated by the Zetasizer
instrument using the Stokes–Einstein equation, assuming that
the nanoemulsion droplets were spherical. Before measure-
ment, the samples were diluted at a ratio of 1 : 100 (v/v) in an
appropriate buﬀer solution with the same pH as the aqueous
phase of the sample (citrate buﬀer (10 mM, pH 2) for stomach
step and phosphate buﬀer (10 mM, pH 7) for before digestion
and small intestine steps21) at room temperature to avoid
multiple scattering eﬀects. The measurements were performed
at least in triplicate.
The particle size distribution was also measured by the
Mastersizer instrument, which measures the angular depen-
dence of the intensity of laser light scattered by a dilute emul-
sion and then nds the particle size distribution that gives the
best t between the experimental measurements and predic-
tions made using light-scattering theory (Mie theory). To avoid
multiple scattering eﬀects the emulsions were diluted in
distilled water at a ratio of 1 : 100 (v/v).
Data tting – particle size distribution (d4,3¼ (Pnidi4/
P
nidi3)
where ni is the number of droplets of diameter di) of the
emulsions was recorded before and during simulated digestion
using refractive indices of 1.47 and 1.33 for droplet and
dispersed (water) phase respectively.2.5 z-Potential
The z-potential values of nanoemulsions at diﬀerent stages of
digestion were measured using a particle electrophoresis
instrument (Malvern Instruments, Worcestershire, UK). The
z-potential was determined by measuring the direction and
velocity of droplet movement in the applied electric eld and
was calculated by the instrument using the Smoluchowski
model.
The samples were diluted 100 times in appropriate buﬀer
solution (citrate buﬀer (10 mM, pH 2) for the stomach step and
phosphate buﬀer (10 mM, pH 7) for before digestion and small
intestine steps21) at room temperature before measurement and
each individual z-potential measurement was determined from
the average of three readings.2.6 Confocal microscopy
The microstructure of the oil droplets in the emulsion was
studied using a confocal scanning laser microscope (Leica TCS
SP5 DM6000B, Heidelberg, Germany) with an 100 oil immer-
sion objective lens. Samples were stained with Nile Red
(9-diethylamino-5H-benzo[a]phenoxazine-5-one, 0.25 mg ml1
in dimethyl sulfoxide, 1 : 10 (dye:sample), v/v), which enabled
the oil droplets to become visible. Slides were prepared by
taking a portion of the stained emulsion solution and placing inThis journal is ª The Royal Society of Chemistry 2013a concave glass microscope slide and covering with a glass
cover slip.2.7 Free fatty acid release
A measure of lipolysis is the production of free fatty acids (FFA)
with increased digestion time, which leads to a decrease in the
pH of the system. A pH-stat automatic titration unit (TIM 856
titration manager, Titralab, Radiometer analytical) was used to
automatically monitor the pH and maintain it at a pre-set value
by titrating with 0.05 M NaOH solution. The volume of NaOH
added to the emulsion was recorded, and used to calculate the
concentration of FFA generated by lipolysis.
A sample of emulsion was collected from the HGS aer 120
min (aer stomach simulation) and diluted in an appropriate
quantity of small intestinal electrolyte solution (SIES), to obtain
the same emulsion concentration as in the HGS at the end of
digestion. Then pancreatin and bile extract were added and
back titration was used to measure the total free fatty acids.
Aer incubation of the emulsions at pH 7.0 for a certain period
of time, the pH was rapidly increased with NaOH to pH 9.0 to
stop the reaction and to favour the release of FFA. Therefore, the
total FFA was assessed by titration, measuring the volume
necessary to reach pH 9.0.22 Back titration was performed at pH
9.0 in order to ensure full ionization and titration of free fatty
acids.23
Blank experiments (without pancreatin) were performed in
order to determine the volume of NaOH required to raise the pH
to 9.0. This was required for the calculation of total free fatty
acids liberated according to eqn (1). The quantity of fatty acids





volumeNaOH for sample  volumeNaOH for blank
 C  1000
volumesample
(1)
where C is the molar concentration of the NaOH titrant used
(0.05 in this case).2.8 Curcumin bioavailability
It was assumed that the fraction of the original curcumin that
ended up in the micelle phase was a measure of curcumin
bioavailability.8 Therefore, the curcumin bioavailability at
diﬀerent stages of digestion was determined based on the
methodology described by other authors.8 Briey, 10 ml of the
emulsions were centrifuged (Sorvall evolution RC. Thermo
Scientic) (18 675g) at room temperature for 30 min. The
micelle phase (5 ml) was collected, vortexed with 5 ml of chlo-
roform, and then centrifuged at 651g, at room temperature, for
10 min. The bottom chloroform layer was collected and the
extraction procedure was repeated with the top layer. The
second bottom chloroform layer was added to the previously set
aside chloroform layer, mixed, and analysed by UV-VIS spec-
trophotometer (Genesys 10uV, Thermo Scientic) at 422 nm
(absorbance peak). The concentration of curcumin wasSoft Matter, 2013, 9, 3147–3154 | 3149
Soft Matter Paperdetermined from a previously prepared calibration curve of
absorbance versus curcumin concentration in chloroform.2.9 Statistical analysis
All experiments were carried out in triplicate using freshly
prepared samples. The results were then reported as averages
and standard deviations of these measurements. The statistical
analyses were carried out using analysis of variance, Tukey's
mean comparison test (p < 0.05) and linear regression analysis
(SigmaStat, trial version, 2003, USA).Fig. 2 Static laser light scattering-based particle size distribution curves of cur-
cumin nanoemulsions stabilized by diﬀerent emulsiﬁers: Tween 20 (a); SDS (b)3 Results and discussion
3.1 Inuence of digestion on particle size
Initially, we characterized the change in particle size distribu-
tion of the nanoemulsions as a function of digestion time. Fig. 1
shows the mean hydrodynamic diameter of curcumin nano-
emulsions at diﬀerent stages of the simulated digestion process
namely initial (before digestion), stomach, duodenum, jejunum
and ileum, determined using a dynamic light scattering
methodology.
All the emulsiers tested formed stable nanoemulsions with
z-average diameters of 124.2  8.4, 152.9  2.2 and 119.5  4.5
nm, for Tween 20, SDS and DTAB stabilized nanoemulsions,
respectively. The monodispersity of the nanoemulsions can be
evaluated by its polydispersity index (PDI), which can range
from 0 to 1 (with 0 being monodisperse and 1 being poly-
disperse). The nanoemulsions stabilized by SDS and DTAB
exhibit a narrow size distribution (PDI ¼ 0.19  0.02 and 0.22 
0.01, respectively), whereas the Tween 20 stabilised emulsions
present a lower monodispersity (PDI ¼ 0.42  0.03).
During the simulated digestion, all nanoemulsions showed
an increase in size, although the precise mechanism was not
identied. The increase in droplet size observed could be
attributed to aggregation, coalescence or occulation due to the
action of digestive enzymes as well as changes in pH and ionic
strength. From the data presented it would appear that emul-
sions stabilized with DTAB were the least stable, showing the
greatest increase in particle diameter ( p < 0.05).Fig. 1 Dynamic light scattering-based mean particle diameter of curcumin
nanoemulsions stabilized by diﬀerent emulsiﬁers (Tween 20, SDS and DTAB) as
they pass through an in vitro digestion model.
and DTAB (c). Each stage of in vitro digestion is represented as follows; initial (A),
stomach (-), duodenum (:), jejunum () and ileum (B).
3150 | Soft Matter, 2013, 9, 3147–3154It should be noted that dynamic light scattering has a size
limitation: it is suitable for the measurement of particle diam-
eters up to few microns (#10 mm). Therefore, to detect the
extent to which the emulsion drop diameter had increased, the
emulsions were also analysed using static light scattering
(Fig. 2).
The droplet size distribution of the emulsions obtained
using static light scattering showed that the initial nano-
emulsions had a monomodal size distribution for all emulsier
types. For Tween 20 nanoemulsions (Fig. 2a), aer the addition
of simulated gastric uids, the emulsions started to show a
bimodal distribution, with a second peak in the region of 10 mm
and a corresponding decrease in the area of the rst peak. TheThis journal is ª The Royal Society of Chemistry 2013
Paper Soft Matteraddition of simulated intestinal uids resulted in a multimodal
distribution, with a third peak appearing in the range of
100 mm, and a gradual decrease of the initial peak (centred 
0.1 mm). This result suggests that the change in size distribution
was an eﬀect of digestive enzymes and not an eﬀect of the
change in pH, ionic strength or shear, as there was no change in
the size distribution for the control experiment performed with
everything but the enzyme (data not shown). In the case of SDS
nanoemulsions (Fig. 2b), a more rapid decrease in the nano-
meter size emulsion droplets was observed and a new pop-
ulation of relatively large particles (around 1 mm) was formed as
the emulsions passed through the in vitro system. For DTAB-
stabilized emulsions (Fig. 2c), the nanometer-range peak dis-
appeared and the distribution became multimodal when the
nanoemulsions were subjected to simulated gastric conditions.
Under simulated intestinal conditions, the droplet sizes
increased further, reaching approximately 1000 mm. For nano-
emulsions stabilized with both SDS and DTAB, there was a
signicant decrease in droplets in the nanometer size range,
especially under simulated gastric conditions. The increase in
droplet size and the presence of a multimodal size distribution
cannot be simply explained by the activation or presence of the
digestion enzymes. Our control results (without enzymes – data
not shown) also showed an increase in droplet diameter with
digestion time suggesting that the change in pH, ionic strength
and shear contribute to weakening of the emulsion interface
promoting coalescence of the oil drops. In the case of DTAB this
interfacial weakening could result from the strong binding of
bile salts (an interaction promoted by the strong electrostatic
binding), which are known to displace emulsiers at the
emulsions interface, facilitating the binding of lipase and thus
enabling lipolysis.21 According to other authors, emulsions
stabilized by non-ionic surfactants (such as Tween 20) are more
stable in the acidic gastric environment due to steric repulsion
provided by the polyoxyethylene head group.25
The results obtained by static light scattering (Mastersizer)
are in agreement with the trend observed for the dynamic light
scattering (Zetasizer). However, in general, the hydrodynamic
diameters measured by Zetasizer are lower than thosemeasured
by Mastersizer, which may be explained by the fact that the
larger coalesced droplets rapidly creamed to the top of the
Zetasizer cell and thus escaped to the detection by the laser and
the detection beam passed through an unrepresentative frac-
tion of emulsions containing relatively small droplets.26
These results show that the nature and extent of the changes
in lipid droplet size as the emulsions pass through an in vitro
digestion model depends on the emulsier type, conrming the
results of previous work.14,21 This work, however, also brings
new insight in suggesting that is a contribution made by
changes in pH, ionic strength and shear and highlights the
importance of subjecting the emulsion to the simulated gastric
environment.3.2 Inuence of digestion on emulsion microstructure
The microstructure of the curcumin nanoemulsions stabilized
by diﬀerent emulsiers at each stage of the simulated digestionThis journal is ª The Royal Society of Chemistry 2013was determined by confocal microscopy (Fig. 3a). Due to the size
of the emulsion droplets (nm) before digestion, Brownian
motion prevents the droplets from being clearly visible.
However, with digestion time the size of the droplets increases
thus enabling them to be clearly detected under the confocal
microscope.
The microscopy images show that before digestion, the
nanoemulsions stabilised by Tween 20 contain a greater pop-
ulation of larger droplets compared with the other initial
nanoemulsions, which is in accordance with its higher PDI
value. All curcumin nanoemulsions present a spherical
morphology and during the simulated digestion, a signicant
increase in nanoemulsion particle size was observed, showing
the same tendency obtained with the size results. As demon-
strated with the particle size data in Fig. 2, the confocal images
show that as in vitro digestion progresses, emulsions stabilized
with Tween 20 appear to have a larger droplet size when
compared to emulsions formed with SDS. This however, is
much smaller than the oil droplet size visible aer 120 min of
simulated gastric digestion for the emulsion formed with DTAB.
The confocal images for the later stages of the simulated
digestion of the DTAB emulsion also show a reduction in the
amount of oil drops present. Our explanation for this observa-
tion is that this particular emulsion was highly unstable,
leading to eventual phase separation (Fig. 3b). Therefore, the
confocal images of DTAB-stabilized emulsions from the simu-
lated intestinal stage show small lipid droplets remaining in the
water phase. Our confocal images, in general, suggest a coa-
lescence-based mechanism for the increase in emulsion drop
diameter. There also appears to be possible clustering of
emulsion drops of the emulsion stabilized with Tween 20 in
the ileum.
These results suggest that the stability of nanoemulsions to
coalescence during digestion is strongly aﬀected by the initial
emulsier. The emulsier type inuences the ability of lipase to
come in contact with the emulsied lipid, and this, together
with the production of free fatty acids (FFA), monoacylglycerols
(MAG) and diacylgycerides (DAG) at the droplet surfaces during
lipid digestion will modify the emulsion interface. These
surface-active products of digestion are ineﬀective at stabilizing
oil-in-water emulsions against coalescence.26 This could explain
the observed changes in emulsion structure as digestion
progressed through the simulated GI tract.3.3 Inuence of digestion on droplet charge
The surface electrical charge (z-potential) of the curcumin
nanoemulsions as they passed through the diﬀerent stages of
the in vitro digestion model provides information about
changes in interfacial composition (Fig. 4).
The z-potential of the initial nanoemulsions stabilized by
Tween 20, SDS and DTAB was 1.03  0.64, 92.86  5.89 and
89.42  7.18 mV, respectively. These electrical charges are to be
expected as Tween 20, SDS and DTAB are non-ionic, anionic and
cationic emulsiers, respectively.
Under simulated gastric conditions, there was no signicant
(p > 0.05) change in the z-potential for the Tween 20 and DTABSoft Matter, 2013, 9, 3147–3154 | 3151
Fig. 3 Confocal images (a) and visual appearance of the samples (b) of curcumin nanoemulsions stabilized by diﬀerent emulsiﬁers (Tween 20, SDS and DTAB) as they
pass through an in vitro digestion model. The scale bar for all confocal images is 25 mm.
Fig. 4 z-potential values of curcumin nanoemulsions stabilized by diﬀerent
emulsiﬁers (Tween 20, SDS and DTAB) as they pass through an in vitro digestion
model.
3152 | Soft Matter, 2013, 9, 3147–3154
Soft Matter Papernanoemulsions. However, in the case of the SDS-stabilized
nanoemulsions, the electrical charge became less negative. The
pKa of SDS is about 1.9;27 therefore, as the environment of
emulsions became more acidic, more SDS molecules are in the
non-ionic state.
The addition of the simulated intestinal uids resulted in all
emulsions having a net negative charge. This led to a reversal of
charge for the DTAB-stabilized nanoemulsions from positive to
negative and the Tween 20-stabilized nanoemulsion gained a
further increase in negative charge. The observed change in
electrical charge can be attributed to the adsorption of anionic
components present in the intestinal juices (e.g. bile salts) or
the presence of free fatty acids (anionic), which are surface-
active products of lipolysis. Bile salts are anionic bio-surfactants
with a high aﬃnity for the oil–water interface and are capable ofThis journal is ª The Royal Society of Chemistry 2013
Fig. 6 Eﬀect of initial emulsiﬁer type on curcumin bioavailability as nano-
emulsions pass through an in vitro digestion model.
Paper Soft Matterdisplacing surface-active compounds from an oil–water inter-
face.21,26,28 Bile salts then remove the digestion products from
the interface and solubilize into the bulk aqueous phase.25,28,29
Although a precise mechanism is diﬃcult to dene from the
current measurements, the high negative charge reported for a
DTAB-stabilized emulsions aer digestion could be a result of
the presence of bile salts at the interface or the digestion
products of TAG (i.e. mono and diglycerides). These data are in
agreement with previous work that has shown that the charge of
emulsions stabilized by Tween 20, lysolecithin, caseinate and
whey protein became more negative when they moved from a
simulated stomach to a small intestine environment.21
At the end of the simulated digestion (ileum), the z-potential
values of all the emulsions were fairly similar irrespective of the
initial droplet charge.
3.4 In vitro digestibility
A measure of digestibility is the production of free fatty acids
(FFA). Fig. 5 shows the results for the production of FFA during
the simulated intestinal digestion of curcumin nanoemulsions
stabilized by diﬀerent emulsiers.
The total FFA produced as measured from the back titration
was the greatest for the Tween 20-stabilized emulsion. This
increased production is attributed to the reduced size of the
emulsion droplet (observed throughout simulated digestion)
which maintains a large surface area for the binding of lipase
and bile salts.
Emulsions stabilized with SDS and DTAB showed a reduced
amount of FFA production in comparison to Tween 20. With the
SDS-stabilized emulsion, charge repulsion could be preventing
eﬀective binding of bile salts and thus the binding of lipase was
not being promoted. In this case the further increase in negative
charge observed in the simulated small-intestine (Fig. 4) could
have been mainly due to the presence of free fatty acids and not
due to the eﬀective binding of bile salts. In the case of the DTAB-
stabilized emulsion, a clear phase separation (as seen in Fig. 3b)
led to a signicant reduction in surface area for enzyme
binding, decreasing the rate of FFA production. Another
explanation presented in the literature is the binding of FFA toFig. 5 Inﬂuence of emulsiﬁer type on the production of total free fatty acids
from curcumin nanoemulsions.
This journal is ª The Royal Society of Chemistry 2013DTAB altering the extent of digestion.30 For all three emulsier
types, FFA production equilibrium was reached. This constant
value could be attributed to the inhibition of lipase activity by
the FFA released.9 Our observations suggest that the size of the
emulsion droplets as well as the emulsier surface charge
aﬀected the total production of FFA.3.5 In vitro curcumin bioavailability
The inuence of the emulsier type on the bioavailability of
curcumin at diﬀerent stages of the simulated digestion process
is presented in Fig. 6.
The bioavailability of curcumin, measured as the curcumin
concentration in the mixed micelle phase, depends on the
emulsier type and on the digestion stage. The curcumin
bioavailability for nanoemulsions stabilized by Tween 20
increased with digestion time and appears to have signicance
only for SDS-stabilized emulsion in the jejunum and ileum.
This behaviour can be attributed to the formation of digestion
products that have the ability to form mixed micelles capable of
solubilizing highly lipophilic components. Also, the greater free
fatty acid production observed in the case of Tween 20-stabi-
lized nanoemulsions (Fig. 5) could explain the high curcumin
bioavailability (in relation to the initial bioavailability) obtained
for the Tween 20-stabilized nanoemulsion.
In contrast, curcumin had very low bioavailability under
simulated intestinal conditions when it was encapsulated in an
emulsion containing DTAB. This eﬀect can be attributed to the
fact that under simulated intestinal conditions, DTAB-stabi-
lized emulsions are highly unstable, leading to phase separa-
tion. Curcumin, which is soluble only in the oil phase, will have
remained in the separated bulk oil, and with this reduced
surface area, the digestive enzymes will not have acted to enable
mixed micelle formation, thus reducing bioavailability. Similar
results were obtained in other work, in which it was observed
that the total amount of b-carotene present in the micellar
phase during each stage of digestion is much higher in small-
sized emulsions compared to emulsions that are larger in size;
this is due to the increased surface area for enzyme
interaction.31Soft Matter, 2013, 9, 3147–3154 | 3153
Soft Matter Paper4 Conclusions
A digestion model involving the in vitro simulation of stomach,
duodenum, jejunum and ileum was used to evaluate the impact
of surface charge on the digestion of the curcumin nano-
emulsions. Although all the nanoemulsions tested were mark-
edly aﬀected by the digestion process, the DTAB-stabilized
emulsions showed the most drastic change in the droplet size
and electrical charge during digestion. The positively charged
surface of DTAB-stabilized nanoemulsions could have
promoted the adsorption of anionic lipase and anionic bile salts
to the oil–water interface; however, the reduction in surface area
would not have promoted enzyme binding to the emulsion
interface. The initial emulsier was also found to impact cur-
cumin bioavailability due to the diﬀerences in the formation of
digestion products that have the ability to form mixed micelles
capable of solubilizing highly lipophilic components. Curcu-
min exhibited a very low bioavailability under intestinal
conditions in the presence of DTAB as emulsier. The higher
curcumin bioavailability observed for Tween 20-stabilized
nanoemulsions (in relation to the initial bioavailability) could
be related to the greater free fatty acid production obtained
for this nanoemulsion as a direct result of the emulsion
droplet size.
The results from this work showed that the behaviour of
nanoemulsions (e.g. free fatty acids release and bioavailability
of the bioactive compound incorporated) during in vitro diges-
tion depends on the charge of the initial emulsier. This work
also highlighted the importance of using a more realistic
digestion model, particularly of subjecting the emulsions to the
simulated gastric environment, once changes in pH, ionic
strength, the gastric enzymes activity and shear impact the
emulsion properties in the small-intestine. The obtained
results will contribute to the development of optimized nano-
emulsion-based delivery systems to protect and release bioac-
tive lipophilic compounds within the human body, for food and
pharmaceutical applications.Acknowledgements
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